Exchange Approval. The Corporation shall have obtained the conditional approval of the TSX-V and any other applicable exchange in respect of the issuance and sale of the Offered Shares and all other necessary regulatory approvals prior to the Closing.
Exchange Approval. The Purchaser shall use its commercially reasonable efforts to obtain the Exchange Approval. If requested by the Purchaser, the Vendor shall assist the Purchaser with obtaining such approval by providing additional information or documentation as may be required by the Exchange.
Exchange Approval. The Investor acknowledges and agrees that each placement of Securities will be subject to approval of the Exchange and there can be no guarantee that the Exchange will approve any issuance of Common Shares or Warrants beyond the first placement. Notwithstanding this clause, the Company and the Resulting Company hereby acknowledge and agree that the Fee and the Warrant Payment shall be due and payable in accordance with the terms of this Agreement, regardless of whether or not Exchange approval is granted. However, the Investor acknowledges that without Exchange approval, the Fee may only be paid in cash (rather than in Common Shares) and in such circumstance the Company shall be obliged to pay the Fee in cash only.
Exchange Approval. On or prior to the Closing Date, the Underlying Shares shall have been approved for listing with the NYSE, upon official notice of issuance.
Exchange Approval. The Purchaser shall have received the conditional approval of the Toronto Stock Exchange to issue the Consideration Shares.
Exchange Approval. Subject to the provisions of Section 6.2 below, the parties acknowledge that any issuance of stock by the Company of its common stock, including with respect to the license fees, patent expense reimbursements, milestones payments and share exchanges referred to above, is subject to the prior approval of the NYSE MKT or any other exchange upon which the shares of the Company are listed and if required by such exchange or any other rule or regulation applicable to Synbiomics or the Company, shareholder approval.
Exchange Approval. The Vendor shall have received receipt of conditional approval from the TSXV (or such other Canadian marketplace on which the common shares of the Vendor are listed for trading if not the TSXV) for the transactions contemplated by this Agreement including, for greater certainty, the acquisitions of each of MMJ International, Marigold Acquisitions and MMJ Colombia in accordance with the Pre-Closing Re-Organization.
Exchange Approval. The approval of the Exchange shall have been obtained by CGGC to enable the Col-Care Transaction to qualify as CGGC’s “qualifying transaction” and for the listing of the CGGC Common Shares on the Exchange after the Effective Time.
Exchange Approval. If required by the TSX Venture Exchange, Voyager shall have received the approval (or conditional approval) of the TSX Venture Exchange for the transactions contemplated by this Agreement, subject only to satisfaction by Voyager of customary post- closing conditions imposed by the TSX Venture Exchange (the “TSXV Approval”).
Exchange Approval. This Agreement shall be subject to the approval (the "Approval") of the TSX Venture Exchange, and LVH shall use its commercially reasonable best efforts to obtain such approval as expeditiously as possible.
